It doesn't take long for one to realize hardly any treatment is absolutely life-saving.
No, not even transfusion for severe trauma, surgery for cancer, or thrombolytics for heart attack. Not everyone survive after the treatment.
"You are trying to be picky," you may argue, "Of course all treatment with evidence-based efficacy and a reasonable price should be available to everyone."
By now, you may predict the question of someone who has studied Lee Tien Ming: How efficacious is acceptable, and what price is reasonable ?
But no, I would ask: Who is going to compare and decide on the price and efficacy (alas, cost and effectiveness) ?
Should it be our government or health care administrators ? Yes, they can decide from the society or public system point of view - and they should do so in order to determine which treatment should be freely available to all citizens.
But no. Neither the government nor administrators should decide for individuals. Some patients value their own life and are sufficiently well to do; they are willing to pay slightly more for a lower margin of benefit. They have the right to choose - and the right to know they have something to choose.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment